We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

The Investing ‘Edge’ You Didn’t Know You Had

Novice investors worry about not having an ‘edge’, or special knowledge… but taking a long-term view, and being patient, can be just as powerful.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Speak to seasoned investors, and you often discover that they reckon to possess a particular ‘edge’.
 
For some, their edge is the ability to drill down into a company’s financials, and dissect its balance sheet. For others, it’s timing: they reckon that they’re better than average when it comes to knowing when to sell or trim a position. And for others, it’s networking: they’re plugged into industry-specific online groups, for instance, or attend company meetings and presentations, and are generally close to the action.
 
All of which is all very well and good, but it’s not for everyone. And certainly, speaking personally, I wouldn’t lay claim to be particularly adept at any of those things — although I know people who are.
 
But each of us has another edge that we can use. And too few of us do. Which I’ve been reminded of in recent days, as I’ve watched investor reaction to several company announcements.

What counts is time in the market, not timing the market

 There’s an old investment adage that you’ve almost certainly heard. It’s the words in the heading just above this sentence, in fact. In short, the secret to long-term investment success in time in the market, and not timing the market.
 
And as sayings go, there’s a lot of truth in it. Because even for people who reckon to be good at it, it’s extraordinarily difficult to correctly call the market’s twists and turns, and rises and falls.
 
And yes, I’m rubbish at that as well.
 
When I bought into an S&P 500 index tracker just over a year ago, for instance, I’d no idea that the already heady American stock market was going to motor on to deliver a 27% return. And when I sold out of China at the New Year — banking some decent gains in the process — I’d no idea that the Chinese stock market would rise a further 30%.
 
Similarly, when I bought GKN in 2010, I’d no idea that it would deliver a 144% return (excluding dividends), or that 2013’s purchase of a chunk of High Street bakery chain Greggs would deliver a meteoric 160% return — again, excluding dividends.
 
All of these things looked unlikely at the time, and certainly weren’t what I was expecting.

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Be in it for the long haul

Which doesn’t really matter, thanks to the investing edge that I reckon I do have. Which is patience.

That’s right: patience.
 
Because I don’t go into investments expecting heady gains. At least, not in timescales measured in a handful of years. It’s great when it happens, of course. But as I wasn’t expecting it, I can hardly claim any credit.
 
What I can claim credit for is spotting what I consider to be undervalued companies — and markets — and buying into them. And then waiting, patiently, for that hidden intrinsic value to ‘out’.
 
Which it usually does. Although not always, of course.

Decent companies, at decent prices

Now let’s be clear. I’m not making big bold bets on investing minnows — the sort of stocks you often find on London’s AIM market, for instance. Those, I leave for others.
 
Nor am I buying into what are euphemistically called ‘special situations’. Again, I leave those to others, although I’m not averse to buying into an investment fund which claims to be good at spotting (and profiting from) such situations.
 
Nor am I buying what might be called ‘extreme value’ shares — such as BP, right after the Gulf of Mexico oil well blowout, for instance.

So what am I doing?

That’s easy. I’m buying what I think are modest stakes in well-managed businesses, which — for a variety of reasons — look temporarily cheap.

Last week I topped up on Royal Dutch Shell, for instance. Earlier in the year I bought into specialist engineering group Fenner, which has been hit by the mining slump. Last summer, GlaxoSmithKline looked cheap.
 
And so on, and so on.
 
And here comes the edge. Once bought, I don’t watch over the shares like a hawk, ready to sell on the slightest bit of bad news. In fact, after I’ve bought them, many such shares get even cheaper, before recovering.
 
Which is fine, because I’m in it for the long run, and I know that the odds are good that these shares’ fortunes will eventually turn.
 
And I can be patient enough to wait while that happens. But can you?

Malcolm owns shares in BP, Royal Dutch Shell, Fenner, GKN, Greggs and GlaxoSmithKline.  The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Close-up of British bank notes
Investing Articles

How are these FTSE 100 and FTSE 250 dividend stocks so cheap?!

Discover which FTSE 100 and FTSE 250 dividend stocks Royston Wild thinks are trading under value -- including a top-quality…

Read more »

Front view photo of a woman using digital tablet in London
Value Shares

How has Sage become one of the FTSE 100’s best bargain shares?

Sales and profits keep growing at double-digit rates. So why are Sage's share struggling? Royston Wild discusses this FTSE share.

Read more »

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Can the Rolls-Royce share price reach £15.97 by the end of August?

The Rolls-Royce share price has had a solid run in the last year. Muhammad Cheema takes a look at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 1,200% in 5 years, here’s why Nvidia could still be a brilliant value stock

An exciting new announcement that could reshape the PC industry has just pushed Nvidia stock... well, just about nowhere really.

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How investing £4.50 a day could set you on the way to a £1,505 monthly second income

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »

Investing Articles

Up 103% with a P/E of 261 — is this FTSE 100 stock still worth buying?

One FTSE 100 stock is quietly moving higher while most investors are still looking elsewhere — is the market missing…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

The smart money thinks AI stocks look risky — but is there still a chance to buy?

According to fund managers, the AI trade is getting crowded. But they still seem to think it’s the place to…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Barclays shares are 11% below their 52-week high. Could they be a bit of a bargain to consider?

Overpriced or one of the FTSE 100’s hidden gems? James Beard takes a closer look at how the market is…

Read more »